Dose Therapeutics
Robert Sprague has spent over seven years in venture development, licensing, startup operations, and business incubation.
He spent five years in end-to-end product development, including the management of activities from pre-IND to first approval/launch for novel therapeutic in orphan oncology space.
Robert spent over 10 years in cross-functional team leadership and alliance management in startup, small company, and large company environments.
He has an MBA with a background in Integrative Biology (multiple publications, multiple graduate degrees).
This person is not in any offices
Dose Therapeutics
Dose Therapeutics is a biotechnology company that discovers and develops cutting-edge medicines for treating unmet medical needs.